Decreased activity of the enzyme paraoxonase-1 (PON1) has been demonstrated in cardiovascular diseases. Statins, the forefront of pharmacotherapy for dyslipidemia, have been shown to enhance PON1 activity but clinical findings have not been conclusive.
Effect of statin therapy on paraoxonase-1 status: A systematic review and meta-analysis of 25 clinical trials / Ferretti, Gianna; Bacchetti, Tiziana; Sahebkar, Amirhossein. - In: PROGRESS IN LIPID RESEARCH. - ISSN 0163-7827. - STAMPA. - 60:(2015), pp. 50-73. [10.1016/j.plipres.2015.08.003]
Effect of statin therapy on paraoxonase-1 status: A systematic review and meta-analysis of 25 clinical trials
FERRETTI, GIANNAWriting – Original Draft Preparation
;BACCHETTI, TIZIANAWriting – Original Draft Preparation
;
2015-01-01
Abstract
Decreased activity of the enzyme paraoxonase-1 (PON1) has been demonstrated in cardiovascular diseases. Statins, the forefront of pharmacotherapy for dyslipidemia, have been shown to enhance PON1 activity but clinical findings have not been conclusive.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
